Summary
Silver (Ag)‐doped PbS (PbS:Ag) thin films of 616 to 745 nm in thickness were prepared on glass substrates via cost‐effective nebulizer spray method by adding different Ag levels from 2% to 8% at 200°C. For solar cell applications, the effect of Ag doping concentration on structural, morphological, optical, photoluminescence, and electrical chattels of PbS thin film has been studied. X‐ray diffraction pattern confirmed the polycrystalline behavior of the prepared PbS:Ag films with cubic crystalline nature. The crystalline size and texture coefficient were increased by increasing Ag doping concentration. From the morphological studies by scanning electron microscope (SEM) and atomic force microscope (AFM), the grain size of the films and surface roughness values were increased for the increase in Ag doping concentration. EDS spectra confirmed the existence of Ag, Pb, and S elements in the select 6% Ag‐doped PbS film. Peaks related to silver oxide started to emerge at 6% of Ag doping level. The optical direct band gap value was reduced from 1.51 to 1.17 eV for Ag doping from 2% to 6% and thereby slightly increased as 1.79 eV for 8% Ag doping level. For all PbS:Ag films, the photoluminescence spectrum emitted a strong near band edge (NBE) emission at approximately 580 nm, meaning better optical quality. Hall effect measurements evidenced that Ag doping provides enhancement on the characteristics of mobility, carrier concentration, and resistivity with p‐type conducting nature. The observed high carrier concentration and low resistivity values were 4.32 × 1014 cm−3 and 80 Ωcm, for 6% Ag‐doped PbS film. The FTO/CdS/PbS:Ag heterostructure solar cell was formed from 6% Ag‐doped film.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.